Do moderate surgical treatment delays influence survival in colon cancer?

Diseases of the Colon and Rectum

Volumn 60, Issue 12, 2017, Pages 1241-1249

  Wanis, Kerollos Nashat ^a   Patel, Sanjay V B ^a   Brackstone, Muriel ^a,b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b LONDON REGIONAL CANCER PROGRAM   (Canada)

Author keywords

Colon cancer; Colon surgery; Recurrence; Survival; Wait times

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT CHEMOTHERAPY; ADJUVANT RADIOTHERAPY; ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COHORT ANALYSIS; COLON ADENOCARCINOMA; COLON CANCER; COLON SURGERY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; ELECTIVE SURGERY; FEMALE; HUMAN; KAPLAN MEIER METHOD; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OVERALL SURVIVAL; RETROSPECTIVE STUDY; SIGNET RING CARCINOMA; THERAPY DELAY; VERY ELDERLY; COLONIC NEOPLASMS; EPIDEMIOLOGY; HOSPITAL MANAGEMENT; MORTALITY; ONTARIO; PATHOLOGY; PROSPECTIVE STUDY; SURVIVAL RATE; TIME FACTOR;

AGED; AGED, 80 AND OVER; APPOINTMENTS AND SCHEDULES; COLONIC NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; ONTARIO; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS;

EID: 85033595578     PISSN: 00123706     EISSN: 15300358     Source Type: Journal    
DOI: 10.1097/DCR.0000000000000857     Document Type: Article

References (31)

1. Siegel R, DeSantis C, Jemal A. Colorectal cancer statistics, 2014: colorectal cancer statistics, 2014. CA Cancer J Clin. 2014;64:104-117.
2. Haggar FA, Boushey RP. Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors. Clin Colon Rectal Surg. 2009;22:191-197.
3. Ramos M, Esteva M, Cabeza E, Campillo C, Llobera J, Aguiló A. Relationship of diagnostic and therapeutic delay with survival in colorectal cancer: a review. Eur J Cancer. 2007;43:2467-2478.
4. Simunovic M, Rempel E, Thériault ME, et al. Influence of delays to nonemergent colon cancer surgery on operative mortality, disease-specific survival and overall survival. Can J Surg. 2009;52:E79-E86.
5. Helewa RM, Turner D, Park J, et al. Longer waiting times for patients undergoing colorectal cancer surgery are not associated with decreased survival. J Surg Oncol. 2013;108:378-384.
6. Amri R, Bordeianou LG, Sylla P, Berger DL. Treatment delay in surgically-treated colon cancer: does it affect outcomes? Ann Surg Oncol. 2014;21:3909-3916.
7. Gillis A, Dixon M, Smith A, Law C, Coburn NG. A patientcentred approach toward surgical wait times for colon cancer: a population-based analysis. Can J Surg. 2014;57:94-100.
8. Cancer Care Ontario. Target wait times for cancer surgery in Ontario, final report. https://www.cancercare.on.ca/common/pages/UserFile.aspx?fileId=43244. Accessed July 1, 2016.
9. Simunovic M, Thériault ME, Paszat L, et al. Using administrative databases to measure waiting times for patients undergoing major cancer surgery in Ontario, 1993-2000. Can J Surg. 2005;48:137-142.
10. Sauer R, Becker H, Hohenberger W, et al.; German Rectal Cancer Study Group. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004;351:1731-1740.
11. Nordlinger B, Sorbye H, Glimelius B, et al. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet. 2008;371:1007-1016.
12. Yun YH, Kim YA, Min YH, et al. The influence of hospital volume and surgical treatment delay on long-term survival after cancer surgery. Ann Oncol. 2012;23:2731-2737.
13. Redaniel MT, Martin RM, Blazeby JM, Wade J, Jeffreys M. The association of time between diagnosis and major resection with poorer colorectal cancer survival: a retrospective cohort study. BMC Cancer. 2014;14:642.
14. Nakamura T, Matsumine A, Matsubara T, Asanuma K, Uchida A, Sudo A. The symptom-to-diagnosis delay in soft tissue sarcoma influence the overall survival and the development of distant metastasis: delay in soft tissue sarcoma. J Surg Oncol. 2011;104:771-775.
15. Liedberg F, Anderson H, Månsson W. Treatment delay and prognosis in invasive bladder cancer. J Urol. 2005;174:1777-1781.
16. González-Barcala FJ, García-Prim JM, Alvarez-Dobaño JM, et al. Effect of delays on survival in patients with lung cancer. Clin Transl Oncol. 2010;12:836-842.
17. Richards MA, Westcombe AM, Love SB, Littlejohns P, Ramirez AJ. Influence of delay on survival in patients with breast cancer: a systematic review. Lancet. 1999;353:1119-1126.
18. Iversen LH, Antonsen S, Laurberg S, Lautrup MD. Therapeutic delay reduces survival of rectal cancer but not of colonic cancer. Br J Surg. 2009;96:1183-1189.
19. Currie AC, Evans J, Smith NJ, Brown G, Abulafi AM, Swift RI. The impact of the two-week wait referral pathway on rectal cancer survival. Colorectal Dis. 2012;14:848-853.
20. Thorne K, Hutchings HA, Elwyn G. The effects of the two-week rule on NHS colorectal cancer diagnostic services: a systematic literature review. BMC Health Serv Res. 2006;6:43.
21. Walsh SR, Gilson NL, Brown K, Novell JR. Trends in colorectal cancer survival following the 2-week rule. Colorectal Dis. 2007;9:207-209.
22. Zafar A, Mak T, Whinnie S, Chapman MA. The 2-week wait referral system does not improve 5-year colorectal cancer survival. Colorectal Dis. 2012;14:e177-e180.
23. Rai S, Kelly MJ. Prioritization of colorectal referrals: a review of the 2-week wait referral system. Colorectal Dis. 2007;9:195-202.
24. Porter GA, Inglis KM, Wood LA, Veugelers PJ. Access to care and satisfaction in colorectal cancer patients. World J Surg. 2005;29:1444-1451.
25. Mathews M, Ryan D, Bulman D. Patient-expressed perceptions of wait-time causes and wait-related satisfaction. Curr Oncol. 2015;22:105-112.
26. Mathews M, Ryan D, Bulman D. What does satisfaction with wait times mean to cancer patients? BMC Cancer. 2015;15:1017.
27. Iacopetta B. Are there two sides to colorectal cancer? Int J Cancer. 2002;101:403-408.
28. Matanoski G, Tao X, Almon L, Adade AA, Davies-Cole JO. Demographics and tumor characteristics of colorectal cancers in the United States, 1998-2001. Cancer. 2006;107(5 suppl):1112-1120.
29. Barton JB, Langdale LA, Cummins JS, et al. The utility of routine preoperative computed tomography scanning in the management of veterans with colon cancer. Am J Surg. 2002;183:499-503.
30. Mauchley DC, Lynge DC, Langdale LA, Stelzner MG, Mock CN, Billingsley KG. Clinical utility and cost-effectiveness of routine preoperative computed tomography scanning in patients with colon cancer. Am J Surg. 2005;189:512-517.
31. Sjövall A, Blomqvist L, Egenvall M, Johansson H, Martling A. Accuracy of preoperative T and N staging in colon cancer: a national population-based study. Colorectal Dis. 2016;18:73-79.